Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


17.06.2024

2 Antiviral Res
16 BMJ
2 J Clin Microbiol
1 J Epidemiol Community Health
9 J Infect Dis
5 J Virol
2 JAMA
8 Lancet
3 N Engl J Med
2 PLoS Comput Biol
28 PLoS One
3 Proc Natl Acad Sci U S A
5 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antiviral Res

  1. ZHAI G, Fu W, Yuan S, Sun P, et al
    A fusion protein approach to integrate antiviral and anti-inflammatory activities for developing new therapeutics against influenza A virus infection.
    Antiviral Res. 2024 Jun 9:105924. doi: 10.1016/j.antiviral.2024.105924.
    PubMed         Abstract available

  2. LI J, Cui H, Yao Y, Niu J, et al
    Anti-influenza activity of CPAVM1 protease secreted by Bacillus subtilis LjM2.
    Antiviral Res. 2024 Jun 6:105919. doi: 10.1016/j.antiviral.2024.105919.
    PubMed         Abstract available


    BMJ

  3. MAHASE E
    Bird flu: First person with confirmed H5N2 infection dies.
    BMJ. 2024;385:q1260.
    PubMed        

  4. SMITH C
    Infected blood inquiry: justice will only be delivered when all the recommendations are acted upon.
    BMJ. 2024;385:q1256.
    PubMed        

  5. VIZE R
    What are the early election promises on health?
    BMJ. 2024;385:q1258.
    PubMed        

  6. MAHASE E
    Bird flu: Australia records first human case of H5N1.
    BMJ. 2024;385:q1281.
    PubMed        

  7. DEAN E
    Why I . . . make free flight aircraft.
    BMJ. 2024;385:q1157.
    PubMed        

  8. KMIETOWICZ Z
    Sixty seconds on . . . flying.
    BMJ. 2024;385:q1266.
    PubMed        

  9. TORJESEN I
    Hospital doctors in Wales to vote on enhanced pay deal for 2023-24.
    BMJ. 2024;385:q1273.
    PubMed        

  10. MAHASE E
    RCP president is asked to resign over handling of physician associates row.
    BMJ. 2024;385:q1291.
    PubMed        

  11. LAL N
    Study on adverse effects following Covaxin stirs heated debate in India.
    BMJ. 2024;385:q1300.
    PubMed        

  12. IACOBUCCI G
    Tories pledge to slash number of NHS managers to fund health spending.
    BMJ. 2024;385:q1297.
    PubMed        

  13. SADGROVE NEE STACEY C
    Help create an opportunity to learn together.
    BMJ. 2024;385:q868.
    PubMed        

  14. SHEPHERD A
    Striking doctors rally in Stormont.
    BMJ. 2024;385:q1280.
    PubMed        

  15. MAHASE E
    Bird flu: India reports human case of H9N2 in 4 year old.
    BMJ. 2024;385:q1317.
    PubMed        

  16. RIMMER A
    Four year medical degree set to launch in 2026, says NHS England.
    BMJ. 2024;385:q1312.
    PubMed        


  17. Seven days in medicine: 5-11 June 2024.
    BMJ. 2024;385:q1278.
    PubMed        

  18. KMIETOWICZ Z
    Labour vows to "fix NHS again" after Tories leave it "broken".
    BMJ. 2024;385:q1315.
    PubMed        


    J Clin Microbiol

  19. MARGULIS M, Rohana H, Erster O, Mandelboim M, et al
    Highly sensitive extraction-free saliva-based molecular assay for rapid diagnosis of SARS-CoV-2.
    J Clin Microbiol. 2024;62:e0060024.
    PubMed         Abstract available

  20. POWELL EA, Greninger AL, Marlowe EM, Naccache SN, et al
    Proceedings of the Clinical Microbiology Open 2023: discussions about pandemic preparedness.
    J Clin Microbiol. 2024;62:e0014424.
    PubMed         Abstract available


    J Epidemiol Community Health

  21. RHEAD R, Wels J, Moltrecht B, Shaw RJ, et al
    Long COVID and financial outcomes: evidence from four longitudinal population surveys.
    J Epidemiol Community Health. 2024;78:458-465.
    PubMed         Abstract available


    J Infect Dis

  22. ATTUR M, Petrilli C, Adhikari S, Iturrate E, et al
    Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.
    J Infect Dis. 2024;229:1740-1749.
    PubMed         Abstract available

  23. HARTELOH P, van Mechelen R
    Reply to Mattiuzzi and Lippi.
    J Infect Dis. 2024;229:1930.
    PubMed        

  24. MATTIUZZI C, Lippi G
    Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus Disease 2019 in Italy.
    J Infect Dis. 2024;229:1928-1929.
    PubMed        

  25. GAY L, Rouviere MS, Mezouar S, Richaud M, et al
    Vgamma9Vdelta2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19.
    J Infect Dis. 2024;229:1759-1769.
    PubMed         Abstract available

  26. IVERSEN KK, Ronit A, Ahlstrom MG, Nordestgaard BG, et al
    Lung Function Trajectories in Mild COVID-19 With 2-year Follow-up.
    J Infect Dis. 2024;229:1750-1758.
    PubMed         Abstract available

  27. CARROLL TD, Wong T, Morris MK, Di Germanio C, et al
    Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
    J Infect Dis. 2024 Jan 12:jiad568. doi: 10.1093.
    PubMed         Abstract available

  28. ZHANG Y, Zhou Y, Chen J, Wu J, et al
    Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.
    J Infect Dis. 2023 Dec 27:jiad572. doi: 10.1093.
    PubMed         Abstract available

  29. LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al
    Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
    J Infect Dis. 2024;229:1728-1739.
    PubMed         Abstract available

  30. LIM SY, Kim JW, Kim JY, Kang SW, et al
    The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study.
    J Infect Dis. 2024;229:1722-1727.
    PubMed         Abstract available


    J Virol

  31. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    PubMed         Abstract available

  32. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    PubMed         Abstract available

  33. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    PubMed         Abstract available

  34. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    PubMed         Abstract available

  35. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    PubMed         Abstract available


    JAMA

  36. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed        

  37. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed        


    Lancet

  38. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed         Abstract available

  39. ANIRVAN P
    Blowing in the wind-India's health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed        

  40. MOHAPATRA PR
    Responding to India's data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed        

  41. THE LANCET
    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    PubMed        

  42. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed        

  43. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial - Authors' reply.
    Lancet. 2024;403:2484-2485.
    PubMed        

  44. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed        

  45. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed        


    N Engl J Med

  46. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    PubMed        

  47. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts - Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed        

  48. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed        


    PLoS Comput Biol

  49. HILL EM, Petrou S, de Lusignan S, Yonova I, et al
    Correction: Seasonal influenza: Modelling approaches to capture immunity propagation.
    PLoS Comput Biol. 2024;20:e1012213.
    PubMed         Abstract available

  50. RAWSON T, Hinsley W, Sonabend R, Semenova E, et al
    The impact of health inequity on spatial variation of COVID-19 transmission in England.
    PLoS Comput Biol. 2024;20:e1012141.
    PubMed         Abstract available


    PLoS One

  51. AMANI B, Amani B
    Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298772.
    PubMed         Abstract available

  52. KAKEE S, Kanai K, Tsuneki-Tokunaga A, Okuno K, et al
    Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children.
    PLoS One. 2024;19:e0299445.
    PubMed         Abstract available

  53. MORGENSTERN C, Laydon DJ, Whittaker C, Mishra S, et al
    The interaction of disease transmission, mortality, and economic output over the first 2 years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0301785.
    PubMed         Abstract available

  54. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2024;19:e0305160.
    PubMed         Abstract available

  55. CHANG O, Levitt A, Khalid M, Kodeeswaran S, et al
    The prevalence of mental health and addiction concerns and factors associated with depression and anxiety during the COVID-19 pandemic in Ontario, Canada: A cross-sectional study.
    PLoS One. 2024;19:e0305229.
    PubMed         Abstract available

  56. WU Y, Namilae S, Srinivasan A, Mubayi A, et al
    Parametric analysis of SARS-CoV-2 dose-response models in transportation scenarios.
    PLoS One. 2024;19:e0301996.
    PubMed         Abstract available

  57. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2024;19:e0305043.
    PubMed         Abstract available

  58. MOJEBI A, Wu P, Keeping S, Hale B, et al
    Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.
    PLoS One. 2024;19:e0303560.
    PubMed         Abstract available

  59. IBRAHIM MR, Lyons T
    FaceTouch: Detecting hand-to-face touch with supervised contrastive learning to assist in tracing infectious diseases.
    PLoS One. 2024;19:e0288670.
    PubMed         Abstract available

  60. LEE SH, Ten Cate O, Gottlieb M, Horsley T, et al
    The use of virtual nominal groups in healthcare research: An extended scoping review.
    PLoS One. 2024;19:e0302437.
    PubMed         Abstract available

  61. FAIRCLOUGH SJ, Clifford L, Foweather L, Knowles ZR, et al
    Move Well, Feel Good: Feasibility and acceptability of a school-based motor competence intervention to promote positive mental health.
    PLoS One. 2024;19:e0303033.
    PubMed         Abstract available

  62. DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
    COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
    PLoS One. 2024;19:e0305314.
    PubMed         Abstract available

  63. NJUMA LIBWEA J, Esso L, Njoh AA, Ngwa CH, et al
    Generating the evidence to support the establishment of a Respiratory Syncytial Virus surveillance system in Cameroon: A study protocol.
    PLoS One. 2024;19:e0303468.
    PubMed         Abstract available

  64. YUH WT, Kim J, Kim MS, Kim JH, et al
    Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: A national study utilizing the national health insurance database.
    PLoS One. 2024;19:e0305128.
    PubMed         Abstract available

  65. ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
    A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
    PLoS One. 2024;19:e0304616.
    PubMed         Abstract available

  66. AHMED Z, Gu Y, Sinha K, Mutowo M, et al
    A qualitative exploration of the over-the-counter availability of oral contraceptive pills in Australia.
    PLoS One. 2024;19:e0305085.
    PubMed         Abstract available

  67. CHEONG Q, Kazanjian A, Puyat JH
    Easing anxiety symptoms through leisure activities during social isolation: Findings from nationally representative samples.
    PLoS One. 2024;19:e0303585.
    PubMed         Abstract available

  68. OCHWADA-DOYLE FA, Miles N, Hughes JM, Murphy JJ, et al
    Exploring spatio-temporal changes in coastal recreational fisheries and potential links to extreme weather events.
    PLoS One. 2024;19:e0305106.
    PubMed         Abstract available

  69. CHIEN LC, Marquez ER, Smith S, Tu T, et al
    Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
    PLoS One. 2024;19:e0302934.
    PubMed         Abstract available

  70. PENG T, Duong KS, Lu JY, Chacko KR, et al
    Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.
    PLoS One. 2024;19:e0303151.
    PubMed         Abstract available

  71. FEATHERSTONE AB, Mathijssen AJTM, Brown A, Chitlapilly Dass S, et al
    SARS-CoV-2 Delta variant remains viable in environmental biofilms found in meat packaging plants.
    PLoS One. 2024;19:e0304504.
    PubMed         Abstract available

  72. MCHENGA M, Ndasauka Y, Kondowe F, Kainja J, et al
    Mental health is just an Addendum: Assessing stakeholder's perceptions on COVID-19 and mental health services provision in Malawi.
    PLoS One. 2024;19:e0305341.
    PubMed         Abstract available

  73. CHICOINE N, Schnipper N, Griffin J
    The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    PLoS One. 2024;19:e0304416.
    PubMed         Abstract available

  74. YANG J, Fang H
    Integrating Embodied Social Presence Theory and Process Virtualization Theory to assess business process virtualizability: The mediating role of embodied co-presence.
    PLoS One. 2024;19:e0305423.
    PubMed         Abstract available

  75. TROTTA E, Serio G, Monacis L, Carlucci L, et al
    The effects of the COVID-19 pandemic on Italian primary school children's learning: A systematic review through a psycho-social lens.
    PLoS One. 2024;19:e0303991.
    PubMed         Abstract available

  76. CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
    Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
    PLoS One. 2024;19:e0305553.
    PubMed         Abstract available

  77. GONZALEZ SUAREZ ML, Mara KC, Rivera CG, Chesdachai S, et al
    Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    PLoS One. 2024;19:e0303896.
    PubMed         Abstract available

  78. ETTMAN CK, Cohen GH, Abdalla SM, Hatton CR, et al
    Depression and assets during the COVID-19 pandemic: A longitudinal study of mental health across income and savings groups.
    PLoS One. 2024;19:e0304549.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  79. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
    Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
    Proc Natl Acad Sci U S A. 2024;121:e2314262121.
    PubMed         Abstract available

  80. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed         Abstract available

  81. MCGOUGH L, Cobey S
    A speed limit on serial strain replacement from original antigenic sin.
    Proc Natl Acad Sci U S A. 2024;121:e2400202121.
    PubMed         Abstract available


    Vaccine

  82. LI J, Gong L, Li J, Gong Z, et al
    Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster.
    Vaccine. 2024;42:3751-3755.
    PubMed         Abstract available

  83. SHANI M, Hermesh I, Feldhamer I, Reges O, et al
    The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities.
    Vaccine. 2024 May 9:S0264-410X(24)00536-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  84. URQUIDI C, Sepulveda-Penaloza A, Valenzuela MT, Ponce A, et al
    Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs.
    Vaccine. 2024 May 14:S0264-410X(24)00538-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  85. PROSPER P, Rodriguez Puertas R, Guerin DMA, Branda MM, et al
    Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers.
    Vaccine. 2024 May 22:S0264-410X(24)00584-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  86. SOE P, Wong H, Naus M, Muller MP, et al
    mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
    Vaccine. 2024 May 6:S0264-410X(24)00535-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology

  87. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed         Abstract available

  88. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.